Dextroamphetamine

{{DrugProjectFormSinglePage |authorTag={{ |aOrAn=a |hasBlackBoxWarning=Yes |adverseReactions= |blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:

• Content

|fdaLIADAdult======Condition1=====

• Dosing Information

• Dosage

Condition2

• Dosing Information

• Dosage

Condition3

• Dosing Information

• Dosage

Condition4

• Dosing Information

• Dosage

|offLabelAdultGuideSupport======Condition1=====

• Developed by:

• Class of Recommendation:

• Strength of Evidence:

• Dosing Information

• Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Dextroamphetamine in adult patients.

|offLabelAdultNoGuideSupport======Condition1=====

• Dosing Information

• Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dextroamphetamine in adult patients.

|fdaLIADPed======Condition1=====

• Dosing Information

• Dosage

Condition2

There is limited information regarding FDA-Labeled Use of Dextroamphetamine in pediatric patients.

|offLabelPedGuideSupport======Condition1=====

• Developed by:

• Class of Recommendation:

• Strength of Evidence:

• Dosing Information

• Dosage

Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Dextroamphetamine in pediatric patients.

|offLabelPedNoGuideSupport======Condition1=====

• Dosing Information

• Dosage

Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dextroamphetamine in pediatric patients.

|contraindications=* Condition1

|warnings=* Description

Precautions

• Description

|clinicalTrials=There is limited information regarding Clinical Trial Experience of Dextroamphetamine in the drug label.

Miscellaneous

|postmarketing=There is limited information regarding Postmarketing Experience of Dextroamphetamine in the drug label.

Miscellaneous

|drugInteractions=* Drug

• Description

|useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Dextroamphetamine in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Dextroamphetamine during labor and delivery. |useInNursing=There is no FDA guidance on the use of Dextroamphetamine with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Dextroamphetamine with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Dextroamphetamine with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Dextroamphetamine with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Dextroamphetamine with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Dextroamphetamine in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Dextroamphetamine in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Dextroamphetamine in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Dextroamphetamine in patients who are immunocompromised.

|administration=* Oral

• Intravenous

|monitoring=There is limited information regarding Monitoring of Dextroamphetamine in the drug label.

• Description

|IVCompat=There is limited information regarding IV Compatibility of Dextroamphetamine in the drug label.

|overdose====Acute Overdose===

Signs and Symptoms

• Description

Management

• Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Dextroamphetamine in the drug label.

|drugBox= |mechAction=*

|structure=*

File:Dextroamphetamine01.png

This image is provided by the National Library of Medicine.

|PD=There is limited information regarding Pharmacodynamics of Dextroamphetamine in the drug label.

|PK=There is limited information regarding Pharmacokinetics of Dextroamphetamine in the drug label.

|nonClinToxic=There is limited information regarding Nonclinical Toxicology of Dextroamphetamine in the drug label.

|clinicalStudies=There is limited information regarding Clinical Studies of Dextroamphetamine in the drug label.

|howSupplied=*

|fdaPatientInfo=There is limited information regarding Patient Counseling Information of Dextroamphetamine in the drug label.

|alcohol=* Alcohol-Dextroamphetamine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

|brandNames=* ®

|lookAlike=* A® — B®

|drugShortage= }} {{#subobject:

 |Page Name=Dextroamphetamine
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Dextroamphetamine
 |Label Name=Dextroamphetamine11.png

}}

{{#subobject:

 |Label Page=Dextroamphetamine
 |Label Name=Dextroamphetamine11.png

}}